
Medtronic Reports $36.4 Billion Revenue Amid $1.15 Billion Antitrust Verdict
Medtronic plcDescription
What this story covers
Medtronic achieved 8% revenue growth to $36.4 billion, driven by cardiovascular innovation and strategic acquisitions. However, the company faces significant risks, including a $1.15 billion antitrust verdict and a $2.951 billion IRS tax reserve.
Story snapshot
CompanyMedtronic plc
TickerMDT
VariantStandard detailed
Duration10:13
Filing type10-K
PeriodAnnual 2026
IndustryHealthcare & Pharmaceuticals
Accession0001628280-26-044354
Sources1
Full Story Script
Content not available for this story.